Sp3 transcription factor pseudogene (SP3P)

Sp3 transcription factor pseudogene (SP3P) refers to a genomic sequence similar to the SP3 gene but lacks the capability to encode a functional protein. Pseudogenes like SP3P arise through gene duplication or retrotransposition and have accumulated mutations that render them non-functional as protein-coding genes. They often reside in the genome without exerting regulatory or coding roles and are not recognized as molecular drug targets[3]. The functional therapeutic target is instead the protein-coding gene SP3 (Sp3 transcription factor), a zinc finger transcription factor involved in the regulation of numerous genes through GC- or GT-box binding and implicated in cancer biology[1][2][3][4]. SP3P itself is not a recognized therapeutic or diagnostic target, nor is it involved in well-established disease pathways. Key Clarification: If targeting refers to the functional protein, the correct form is "Sp3 transcription factor" ("SP3"), not the pseudogene ("SP3P"). The pseudogene is not a direct target for therapy, biomarker work, or disease association. Common databases (GeneCards, UniProt, OMIM) describe a related pseudogene on chromosome 13 but provide no evidence for a role of the pseudogene itself as a target[3].

Other names

SP3PSP3 pseudogene